Exact Mass: 454.12379680000004
Exact Mass Matches: 454.12379680000004
Found 489 metabolites which its exact mass value is equals to given mass value 454.12379680000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Methotrexate
Methotrexate is only found in individuals that have used or taken this drug. It is an antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate dehydrogenase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. [PubChem]Methotrexate anti-tumor activity is a result of the inhibition of folic acid reductase, leading to inhibition of DNA synthesis and inhibition of cellular replication. The mechanism involved in its activity against rheumatoid arthritis is not known. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists CONFIDENCE standard compound; INTERNAL_ID 2730 D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Corona-virus KEIO_ID M048 Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
epsilon-Viniferin
(7E,7R,8R)-epsilon-Viniferin is found in alcoholic beverages. (7E,7R,8R)-epsilon-Viniferin is isolated from leaves of wine grape (Vitis vinifera) infected with Botrytis cinere
Carfecillin
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic ATC code: G01AA08
Ampelopsin D
Ampelopsin D is found in alcoholic beverages. Ampelopsin D is a constituent of Vitis vinifera (wine grape). Constituent of Vitis vinifera (wine grape). Ampelopsin D is found in alcoholic beverages and fruits.
trans-delta-Viniferin
trans-delta-Viniferin is found in alcoholic beverages. trans-delta-Viniferin is isolated from Vitis vinifera (wine grape
KB 2
Constituent of Artocarpus communis (breadfruit). KB 2 is found in breadfruit and fruits. KB 2 is found in breadfruit. KB 2 is a constituent of Artocarpus communis (breadfruit).
(6R)-5,10-methenyltetrahydrofolate
C20H20N7O6 (454.14750000000004)
(6R)-5,10-methenyltetrahydrofolate is also known as Anhydroleucovorin. (6R)-5,10-methenyltetrahydrofolate is considered to be practically insoluble (in water) and acidic
Amethopterin
Carfecillin
Gnetin C
Henagliflozin
A-D-Glucopyranoside,6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-B-D-fructofuranosyl, 6-acetate2,3,4-tris(2-methylpropanoate)
Viniferin
delta-Viniferin
Delta-viniferin, also known as resveratrol (E)-dehydrodimer or delta-viniferin, is a member of the class of compounds known as 2-arylbenzofuran flavonoids. 2-arylbenzofuran flavonoids are phenylpropanoids containing the 2-phenylbenzofuran moiety. Delta-viniferin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Delta-viniferin can be found in grape wine, which makes delta-viniferin a potential biomarker for the consumption of this food product. Delta-viniferin is a resveratrol dehydrodimer. It is an isomer of epsilon-viniferin. It can be isolated from stressed grapevine (Vitis vinifera) leaves. It is also found in plant cell cultures. or in wine. It can also be found in Rheum maximowiczii . Delta-viniferin, also known as resveratrol (E)-dehydrodimer or δ-viniferin, is a member of the class of compounds known as 2-arylbenzofuran flavonoids. 2-arylbenzofuran flavonoids are phenylpropanoids containing the 2-phenylbenzofuran moiety. Delta-viniferin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Delta-viniferin can be found in grape wine, which makes delta-viniferin a potential biomarker for the consumption of this food product. Delta-viniferin is a resveratrol dehydrodimer. It is an isomer of epsilon-viniferin. It can be isolated from stressed grapevine (Vitis vinifera) leaves. It is also found in plant cell cultures. or in wine. It can also be found in Rheum maximowiczii .
Pallidol
Pallidol is a member of the class of compounds known as indanes. Indanes are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring. Pallidol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Pallidol can be found in grape wine, which makes pallidol a potential biomarker for the consumption of this food product. Pallidol is a resveratrol dimer. It can be found in red wine, in Cissus pallida or in Parthenocissus laetevirens .
Pelargonidin 3-O-glucoside
Tivozanib
C22H19ClN4O5 (454.10439140000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Ampelopsin F
5,10-bis(4-hydroxyphenyl)-4b,5,9b,10-tetrahydroindeno[2,1-a]indene-1,3,6,8-tetrol
7,8,3,4,5-Pentamethoxy-6,6-dimethylpyrano[2,3:5,6]flavone
4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-
2-C-hydroxy-7,8-secoeranthin beta-D-glucopyranoside
C21H26O11 (454.14750460000005)
1,5-dihydroxy-3-methoxybenzene 1-O-(6?-O-galloyl)-beta-D-glucopyranoside|1,5-dihydroxy-3-methoxybenzene-1-O-(6-O-galloyl)-beta-D-glucopyranoside|1-beta-D-(6-O-galloyl)-glucopyranosyloxy-3-methoxy-5-hydroxybenzene|1-O-beta-D-(6O-galloyl)-glucopyranosyl-3-O-methoxy-5-hydroxybenzene
2,4-dihydroxy-6-methylphenyl 6-O-galloyl-beta-D-glucopyranoside|2,4-dihydroxy-6-methylphenyl beta-D-glucopyranoside 6-(3,4,5-trihydroxybenzoate)|myrsinoside A
7-[(beta-D-glucopyranosyl)oxy]-5-hydroxy-2-hydroxymethyl-8-[(2E)-4-hydroxy-3-methylbut-2-enyl]-4H-1-benzopyran-4-one
C21H26O11 (454.14750460000005)
(2R*,5aS,10bR)-5a,10b-dihydro-4,5a,8-trihydroxy-2-(1-hydroxy-1-methylethyl)-10b-(3-methyl-2-buten-1-yl)-2H,3H,6H-benzofuro[3,2-b]pyrano[3,2-f]-[1]benzofuro-5-one|(2S*,5aS,10bR)-5a,10b-dihydro-4,5a,8-trihydroxy-2-(1-hydroxy-1-methylethyl)-10b-(3-methyl-2-buten-1-yl)-2H,3H,6H-benzofuro[3,2-b]pyrano[3,2-f][1]benzofuro-5-one|nigrasin C|nigrasin D
(3R*,6aS,11bR)-6a,11b-dihydro-3,5,6a,9-tetrahydroxy-2,2-dimethyl-11b-(3-methyl-2-buten-1-yl)-2H,4H,6H-benzofuro[3,2-b]pyrano[3,2-g][1]benzopyran-6-one|(3S*,6aS,11bR)-6a,11b-dihydro-3,5,6a,9-tetrahydroxy-2,2-dimethyl-11b-(3-methyl-2-buten-1-yl)-2H,4H,6H-benzofuro[3,2-b]pyrano[3,2-g][1]benzopyran-6-one|nigrasin A|nigrasin B
8-O-acetyl-4beta-hydroxy-3alpha-methoxy-dihydroharpagide|ajureptaside A
3-[3-(3,4-dihydroxybenzyl)-6-hydroxy-2,4-dimethoxyphenyl]-1-(5-hydroxy-2-methoxyphenyl)propan-1-one|alpha,beta-dihydro-3,6-dihydroxy-2,4,6-trimethoxy-3-(3,4-dihydroxybenzyl)chalcone
6-O-(beta-D-glucopyranosyl)-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one
1,4-bis(4-hydroxyphenyl)-2,3-bis(3,5-dihydroxyphentyl)-(1E,3E)-butadiene|parthenocissin M
(E)-trimethyl 1-hydroxy-3-(3-(4-hydroxy-3-methoxyphenyl)acryloyloxy)pentane-1,3,5-tricarboxylate
C21H26O11 (454.14750460000005)
2-methoxy-4-hydroxyphenol 1-O-beta-(6-O-galloyl)glucopyranoside|2-Methyl,1-O-(6-O-3,4,5-trihydroxybenzoyl-beta-D-glucopyranoside)-1,2,4-Benzenetriol|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-galloyl)glucoside|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-O-galloyl)glucoside
3-O-beta-D-[6-(4-hydroxy-3,5-dimethoxybenzoyl)]glucopyranosyl-gamma-pyranone|6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-erigeroside|pyromeconic acid 3-O-beta-D-glucopyranoside 6-(O-4-hydroxy-3,5-dimethoxybenzoate)|pyromeconic acid 3-O-beta-D-glucopyranoside 6-O-(4-hydroxy-3,5-dimethoxybenzoate)
1alpha,9beta-difuranoyloxy-2-oxo-3-enedihydro-beta-agarofuran
2,4-diacetoxy-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-benzo[b]carbazole-5-carbonitrile|Kinamycin D|Ninamycin D
C22H18N2O9 (454.10122579999995)
pallidol
A tetracyclic stilbenoid that is a homodimer obtained by cyclodimerisation of resveratrol.
Acegastrodine
C21H26O11 (454.14750460000005)
Kaempferol tetraacetate
Epsilon-Viniferin
(-)-trans-epsilon-viniferin is a stilbenoid that is the (-)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol. It has a role as a metabolite. It is a member of 1-benzofurans, a polyphenol and a stilbenoid. It is functionally related to a trans-resveratrol. It is an enantiomer of a (+)-trans-epsilon-viniferin. Epsilon-viniferin is a natural product found in Dipterocarpus grandiflorus, Dipterocarpus hasseltii, and other organisms with data available. A stilbenoid that is the (-)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.
Methotrexate
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
7-acetyloxy-2-(3,4-diacetyloxyphenyl)-4-oxochromen-5-yl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.188 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.193
methyl 3-(3,4-dihydroxyphenyl)-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
5-[(2R,3S)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol
(2S,3S,4S,5R,6S)-6-(2,4-dihydroxy-3,6-diphenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
methyl 3-(3,4-dihydroxyphenyl)-2-[[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]methyl]-4-methoxy-5-oxofuran-2-carboxylate
5-[(2R,3S)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol
(2S,3S,4S,5R,6S)-6-(2,4-dihydroxy-3,6-diphenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid [IIN-based on: CCMSLIB00000848542]
(2S,3S,4S,5R,6S)-6-(2,4-dihydroxy-3,6-diphenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid [IIN-based: Match]
CP-671305
CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4428; ORIGINAL_PRECURSOR_SCAN_NO 4426 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4422; ORIGINAL_PRECURSOR_SCAN_NO 4418 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4452; ORIGINAL_PRECURSOR_SCAN_NO 4449 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4515; ORIGINAL_PRECURSOR_SCAN_NO 4511 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4421; ORIGINAL_PRECURSOR_SCAN_NO 4416 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8758; ORIGINAL_PRECURSOR_SCAN_NO 8756 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8781; ORIGINAL_PRECURSOR_SCAN_NO 8779 INTERNAL_ID 361; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8781; ORIGINAL_PRECURSOR_SCAN_NO 8779 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8794; ORIGINAL_PRECURSOR_SCAN_NO 8792 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8805; ORIGINAL_PRECURSOR_SCAN_NO 8802 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8790; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 361; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8811; ORIGINAL_PRECURSOR_SCAN_NO 8809
Ala Cys Asp Phe
C19H26N4O7S (454.15221260000004)
Ala Cys Phe Asp
C19H26N4O7S (454.15221260000004)
Ala Cys Met Met
Ala Asp Cys Phe
C19H26N4O7S (454.15221260000004)
Ala Asp Phe Cys
C19H26N4O7S (454.15221260000004)
Ala Asp Ser Tyr
C19H26N4O9 (454.16997060000006)
Ala Asp Tyr Ser
C19H26N4O9 (454.16997060000006)
Ala Phe Cys Asp
C19H26N4O7S (454.15221260000004)
Ala Phe Asp Cys
C19H26N4O7S (454.15221260000004)
Ala Met Cys Met
Ala Met Met Cys
Ala Ser Asp Tyr
C19H26N4O9 (454.16997060000006)
Ala Ser Tyr Asp
C19H26N4O9 (454.16997060000006)
Ala Tyr Asp Ser
C19H26N4O9 (454.16997060000006)
Ala Tyr Ser Asp
C19H26N4O9 (454.16997060000006)
Cys Ala Asp Phe
C19H26N4O7S (454.15221260000004)
Cys Ala Phe Asp
C19H26N4O7S (454.15221260000004)
Cys Ala Met Met
Cys Cys Asp Asp
C14H22N4O9S2 (454.08281619999997)
Cys Cys Glu Thr
Cys Cys Met Val
Cys Cys Thr Glu
Cys Cys Val Met
Cys Asp Ala Phe
C19H26N4O7S (454.15221260000004)
Cys Asp Cys Asp
C14H22N4O9S2 (454.08281619999997)
Cys Asp Asp Cys
C14H22N4O9S2 (454.08281619999997)
Cys Asp Phe Ala
C19H26N4O7S (454.15221260000004)
Cys Asp Met Ser
Cys Asp Ser Met
Cys Glu Cys Thr
Cys Glu Phe Gly
C19H26N4O7S (454.15221260000004)
Cys Glu Gly Phe
C19H26N4O7S (454.15221260000004)
Cys Glu Thr Cys
Cys Phe Ala Asp
C19H26N4O7S (454.15221260000004)
Cys Phe Asp Ala
C19H26N4O7S (454.15221260000004)
Cys Phe Glu Gly
C19H26N4O7S (454.15221260000004)
Cys Phe Gly Glu
C19H26N4O7S (454.15221260000004)
Cys Gly Glu Phe
C19H26N4O7S (454.15221260000004)
Cys Gly Phe Glu
C19H26N4O7S (454.15221260000004)
Cys Met Ala Met
Cys Met Cys Val
Cys Met Asp Ser
Cys Met Met Ala
Cys Met Ser Asp
Cys Met Thr Thr
Cys Met Val Cys
Cys Ser Asp Met
Cys Ser Met Asp
Cys Thr Cys Glu
Cys Thr Glu Cys
Cys Thr Met Thr
Cys Thr Thr Met
Cys Val Cys Met
Cys Val Met Cys
Asp Ala Cys Phe
C19H26N4O7S (454.15221260000004)
Asp Ala Phe Cys
C19H26N4O7S (454.15221260000004)
Asp Ala Ser Tyr
C19H26N4O9 (454.16997060000006)
Asp Ala Tyr Ser
C19H26N4O9 (454.16997060000006)
Asp Cys Ala Phe
C19H26N4O7S (454.15221260000004)
Asp Cys Cys Asp
C14H22N4O9S2 (454.08281619999997)
Asp Cys Asp Cys
C14H22N4O9S2 (454.08281619999997)
Asp Cys Phe Ala
C19H26N4O7S (454.15221260000004)
Asp Cys Met Ser
Asp Cys Ser Met
Asp Asp Cys Cys
C14H22N4O9S2 (454.08281619999997)
Asp Phe Ala Cys
C19H26N4O7S (454.15221260000004)
Asp Phe Cys Ala
C19H26N4O7S (454.15221260000004)
Asp Phe Ser Ser
C19H26N4O9 (454.16997060000006)
Asp Gly Thr Tyr
C19H26N4O9 (454.16997060000006)
Asp Gly Tyr Thr
C19H26N4O9 (454.16997060000006)
Asp Met Cys Ser
Asp Met Ser Cys
Asp Ser Ala Tyr
C19H26N4O9 (454.16997060000006)
Asp Ser Cys Met
Asp Ser Phe Ser
C19H26N4O9 (454.16997060000006)
Asp Ser Met Cys
Asp Ser Ser Phe
C19H26N4O9 (454.16997060000006)
Asp Ser Tyr Ala
C19H26N4O9 (454.16997060000006)
Asp Thr Gly Tyr
C19H26N4O9 (454.16997060000006)
Asp Thr Tyr Gly
C19H26N4O9 (454.16997060000006)
Asp Tyr Ala Ser
C19H26N4O9 (454.16997060000006)
Asp Tyr Gly Thr
C19H26N4O9 (454.16997060000006)
Asp Tyr Ser Ala
C19H26N4O9 (454.16997060000006)
Asp Tyr Thr Gly
C19H26N4O9 (454.16997060000006)
Glu Cys Cys Thr
Glu Cys Phe Gly
C19H26N4O7S (454.15221260000004)
Glu Cys Gly Phe
C19H26N4O7S (454.15221260000004)
Glu Cys Thr Cys
Glu Phe Cys Gly
C19H26N4O7S (454.15221260000004)
Glu Phe Gly Cys
C19H26N4O7S (454.15221260000004)
Glu Gly Cys Phe
C19H26N4O7S (454.15221260000004)
Glu Gly Phe Cys
C19H26N4O7S (454.15221260000004)
Glu Gly Ser Tyr
C19H26N4O9 (454.16997060000006)
Glu Gly Tyr Ser
C19H26N4O9 (454.16997060000006)
Glu Ser Gly Tyr
C19H26N4O9 (454.16997060000006)
Glu Ser Tyr Gly
C19H26N4O9 (454.16997060000006)
Glu Thr Cys Cys
Glu Tyr Gly Ser
C19H26N4O9 (454.16997060000006)
Glu Tyr Ser Gly
C19H26N4O9 (454.16997060000006)
Phe Ala Cys Asp
C19H26N4O7S (454.15221260000004)
Phe Ala Asp Cys
C19H26N4O7S (454.15221260000004)
Phe Cys Ala Asp
C19H26N4O7S (454.15221260000004)
Phe Cys Asp Ala
C19H26N4O7S (454.15221260000004)
Phe Cys Glu Gly
C19H26N4O7S (454.15221260000004)
Phe Cys Gly Glu
C19H26N4O7S (454.15221260000004)
Phe Asp Ala Cys
C19H26N4O7S (454.15221260000004)
Phe Asp Cys Ala
C19H26N4O7S (454.15221260000004)
Phe Asp Ser Ser
C19H26N4O9 (454.16997060000006)
Phe Glu Cys Gly
C19H26N4O7S (454.15221260000004)
Phe Glu Gly Cys
C19H26N4O7S (454.15221260000004)
Phe Gly Cys Glu
C19H26N4O7S (454.15221260000004)
Phe Gly Glu Cys
C19H26N4O7S (454.15221260000004)
Phe Ser Asp Ser
C19H26N4O9 (454.16997060000006)
Phe Ser Ser Asp
C19H26N4O9 (454.16997060000006)
Gly Cys Glu Phe
C19H26N4O7S (454.15221260000004)
Gly Cys Phe Glu
C19H26N4O7S (454.15221260000004)
Gly Asp Thr Tyr
C19H26N4O9 (454.16997060000006)
Gly Asp Tyr Thr
C19H26N4O9 (454.16997060000006)
Gly Glu Cys Phe
C19H26N4O7S (454.15221260000004)
Gly Glu Phe Cys
C19H26N4O7S (454.15221260000004)
Gly Glu Ser Tyr
C19H26N4O9 (454.16997060000006)
Gly Glu Tyr Ser
C19H26N4O9 (454.16997060000006)
Gly Phe Cys Glu
C19H26N4O7S (454.15221260000004)
Gly Phe Glu Cys
C19H26N4O7S (454.15221260000004)
Gly Ser Glu Tyr
C19H26N4O9 (454.16997060000006)
Gly Ser Tyr Glu
C19H26N4O9 (454.16997060000006)
Gly Thr Asp Tyr
C19H26N4O9 (454.16997060000006)
Gly Thr Tyr Asp
C19H26N4O9 (454.16997060000006)
Gly Tyr Asp Thr
C19H26N4O9 (454.16997060000006)
Gly Tyr Glu Ser
C19H26N4O9 (454.16997060000006)
Gly Tyr Ser Glu
C19H26N4O9 (454.16997060000006)
Gly Tyr Thr Asp
C19H26N4O9 (454.16997060000006)
Met Ala Cys Met
Met Ala Met Cys
Met Cys Ala Met
Met Cys Cys Val
Met Cys Asp Ser
Met Cys Met Ala
Met Cys Ser Asp
Met Cys Thr Thr
Met Cys Val Cys
Met Asp Cys Ser
Met Asp Ser Cys
Met Met Ala Cys
Met Met Cys Ala
Met Met Ser Ser
Met Ser Cys Asp
Met Ser Asp Cys
Met Ser Met Ser
Met Ser Ser Met
Met Thr Cys Thr
Met Thr Thr Cys
Met Val Cys Cys
Ser Ala Asp Tyr
C19H26N4O9 (454.16997060000006)
Ser Ala Tyr Asp
C19H26N4O9 (454.16997060000006)
Ser Cys Asp Met
Ser Cys Met Asp
Ser Asp Ala Tyr
C19H26N4O9 (454.16997060000006)
Ser Asp Cys Met
Ser Asp Phe Ser
C19H26N4O9 (454.16997060000006)
Ser Asp Met Cys
Ser Asp Ser Phe
C19H26N4O9 (454.16997060000006)
Ser Asp Tyr Ala
C19H26N4O9 (454.16997060000006)
Ser Glu Gly Tyr
C19H26N4O9 (454.16997060000006)
Ser Glu Tyr Gly
C19H26N4O9 (454.16997060000006)
Ser Phe Asp Ser
C19H26N4O9 (454.16997060000006)
Ser Phe Ser Asp
C19H26N4O9 (454.16997060000006)
Ser Gly Glu Tyr
C19H26N4O9 (454.16997060000006)
Ser Gly Tyr Glu
C19H26N4O9 (454.16997060000006)
Ser Met Cys Asp
Ser Met Asp Cys
Ser Met Met Ser
Ser Met Ser Met
Ser Ser Asp Phe
C19H26N4O9 (454.16997060000006)
Ser Ser Phe Asp
C19H26N4O9 (454.16997060000006)
Ser Ser Met Met
Ser Tyr Ala Asp
C19H26N4O9 (454.16997060000006)
Ser Tyr Asp Ala
C19H26N4O9 (454.16997060000006)
Ser Tyr Glu Gly
C19H26N4O9 (454.16997060000006)
Ser Tyr Gly Glu
C19H26N4O9 (454.16997060000006)
Thr Cys Cys Glu
Thr Cys Glu Cys
Thr Cys Met Thr
Thr Cys Thr Met
Thr Asp Gly Tyr
C19H26N4O9 (454.16997060000006)
Thr Asp Tyr Gly
C19H26N4O9 (454.16997060000006)
Thr Glu Cys Cys
Thr Gly Asp Tyr
C19H26N4O9 (454.16997060000006)
Thr Gly Tyr Asp
C19H26N4O9 (454.16997060000006)
Thr Met Cys Thr
Thr Met Thr Cys
Thr Thr Cys Met
Thr Thr Met Cys
Thr Tyr Asp Gly
C19H26N4O9 (454.16997060000006)
Thr Tyr Gly Asp
C19H26N4O9 (454.16997060000006)
Val Cys Cys Met
Val Cys Met Cys
Val Met Cys Cys
Tyr Ala Asp Ser
C19H26N4O9 (454.16997060000006)
Tyr Ala Ser Asp
C19H26N4O9 (454.16997060000006)
Tyr Asp Ala Ser
C19H26N4O9 (454.16997060000006)
Tyr Asp Gly Thr
C19H26N4O9 (454.16997060000006)
Tyr Asp Ser Ala
C19H26N4O9 (454.16997060000006)
Tyr Asp Thr Gly
C19H26N4O9 (454.16997060000006)
Tyr Glu Gly Ser
C19H26N4O9 (454.16997060000006)
Tyr Glu Ser Gly
C19H26N4O9 (454.16997060000006)
Tyr Gly Asp Thr
C19H26N4O9 (454.16997060000006)
Tyr Gly Glu Ser
C19H26N4O9 (454.16997060000006)
Tyr Gly Ser Glu
C19H26N4O9 (454.16997060000006)
Tyr Gly Thr Asp
C19H26N4O9 (454.16997060000006)
Tyr Ser Ala Asp
C19H26N4O9 (454.16997060000006)
Tyr Ser Asp Ala
C19H26N4O9 (454.16997060000006)
Tyr Ser Glu Gly
C19H26N4O9 (454.16997060000006)
Tyr Ser Gly Glu
C19H26N4O9 (454.16997060000006)
Tyr Thr Asp Gly
C19H26N4O9 (454.16997060000006)
Tyr Thr Gly Asp
C19H26N4O9 (454.16997060000006)
CAY10506
C20H26N2O4S3 (454.10546360000006)
5,2,4,5-Tetrahydroxy-3-(3-hydroxy-3-methylbutyl)-6,6-dimethylpyrano[2,3:7,8]flavone
Phe-Phe4Cl-OH
C23H19ClN2O6 (454.09315840000005)
Phe4Cl-Phe-OH
C23H19ClN2O6 (454.09315840000005)
His-TyrMe-OH
trans-delta-Viniferin
ampelopsin
5-iodo-7Z,10Z,13Z,16Z,19Z-docosapentaen-4-olide
C22H31IO2 (454.13686959999995)
Succinimidyl 4-[3,5-Dimethyl-4-(4-nitrobenzyloxy)phenyl]-4-oxobutyrate
4-methoxyphenyl 2,3,4,6-tetra-o-acetyl-beta-d-glucopyanoside
C21H26O11 (454.14750460000005)
3-[(4-Methyl-3-nitrophenyl)sulfonyl]-2-(2,4,5-trimethoxyphenyl)-1 ,3-thiazolidine
Sucrose acetate isobutyrate
4-Methylphenyl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-glucopyranoside
Dichlorisone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids Dichlorisone acetate is a synthetic glucocorticoid corticosteroid used as an anti-inflammatory agent.
4-METHOXYPHENYL 2,3,4,6-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSIDE
C21H26O11 (454.14750460000005)
Amethopterin
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
4,4-Bis(diethoxyphosphono-methyl)-Biphenyl
C22H32O6P2 (454.16740319999997)
4-methoxyphenyl 2,3,4,6-tetra-o-acetyl-alpha-d-mannopyranoside
C21H26O11 (454.14750460000005)
3-(3-Fluorophenyl)-1-[2-hydroxy-4,6-bis(phenylmethoxy)phenyl]-2-propen-1-one
Quinolinium,1-ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]-, iodide (1:1)
LOFEPRAMINE HYDROCHLORIDE
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-2,4(1H,3H)-pyrimidinedione
Nafcillin sodium monohydrate
C21H23N2NaO6S (454.11744580000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
1-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine
5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Sulfonamide
C19H23ClN4O5S (454.10776180000005)
Vatinoxan Hydrochloride
C20H27ClN4O4S (454.1441452000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
(+)-epsilon-Viniferin
Constituent of wine grapes Vitis vinifera. (7E,7S,8S)-epsilon-Viniferin is found in alcoholic beverages and fruits.
Quadrangularin A
An indane-derived stilbenoid that is a homodimer obtained by cyclodimerisation of resveratrol.
Ampelopsin B
A heterotetracyclic stilbenoid that is a homodimer obtained by cyclodimerisation of resveratrol.
Cis-epsilon-viniferin
Isolated from wine grapes. cis-epsilon-Viniferin is found in fruits.
Phenol, 4-((5-(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinyl)amino)-
N-[2-[[2-(4-methylphenyl)-1H-indol-3-yl]thio]ethyl]-2-oxo-1-benzopyran-3-carboxamide
(R)-2-(4-((((2-((Benzo(1,3)dioxol-5-yl)oxy)pyridin-3-yl)carbonyl)amino)methyl)-3-fluorophenoxy)propionic acid
4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate
(2s)-2-[3-(Aminomethyl)phenyl]-3-[(R)-Hydroxy{(1r)-2-Methyl-1-[(Phenylsulfonyl)amino]propyl}phosphoryl]propanoic Acid
C20H27N2O6PS (454.13273720000007)
4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate
Tivozanib
C22H19ClN4O5 (454.10439140000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
(6R)-5,10-methenyltetrahydrofolate
C20H20N7O6- (454.14750000000004)
A dicarboxylic acid anion arising from deprotonation of both carboxylic acid functions of (6R)-5,10-methenyltetrahydrofolic acid. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
8-Amino-8-demethylriboflavin 5-phosphate
C16H17N5O9P-3 (454.07638620000006)
3-(3,5-Dihydroxyphenyl)-4-hydroxy-2-(4-hydroxyphenyl)-6-[(E)-4-hydroxystyryl]-2,3-dihydrobenzofuran
nigrasin C
An extended flavonoid that is 2,3,5a,10b-tetrahydro-5H-[1]benzofuro[3,2-b]furo[3,2-g]chromene substituted by hydroxy groups at positions 4, 5a and 8, a 2-hydroxypropan-2-yl group at position 2, a prenyl group at position 10b and an oxo group at position 5. It has been isolated from the twigs of Morus nigra.
nigrasin D
An extended flavonoid that is the 2R*-diastereomer of nigrasin C. It has been isolated from the twigs of Morus nigra.
nigrasin A
An extended flavonoid that is 3,4,6a,11b-tetrahydro-2H,6H-[1]benzofuro[3,2-b]pyrano[3,2-g]chromene substituted by hydroxy groups at positions 3, 5, 6a and 9, geminal methyl groups at positions 2, an oxo group at position 6 and a prenyl group at position 11b. It has been isolated from the twigs of Morus nigra.
nigrasin B
An extended flavonoid that is the 3S*-diastereomer of nigrasin A. It has been isolated from the twigs of Morus nigra.
6-[(2r)-4-(4-Benzyl-7-Chlorophthalazin-1-Yl)-2-Methylpiperazin-1-Yl]pyridine-3-Carbonitrile
[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-[5-[(4-chlorophenoxy)methyl]-2-furanyl]methanone
4-[4-[(5Z)-5-[(4-ethylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
(+)-cis-epsilon-Viniferin
A stilbenoid that is the (+)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.
N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide
C24H26N2O3S2 (454.13847660000005)
4-[[4-ethyl-5-[(2-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)-3-oxobutanamide
C23H26N4O4S (454.16746760000007)
2-[[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
C19H17F3N4O4S (454.09225580000003)
N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide
N-[(4-chlorophenyl)methyl]-5,12-dioxo-2R-phenyl-1-oxa-4-azacyclododec-8E-ene-6S-acetamide
C25H27ClN2O4 (454.16592520000006)
(2-anilino-2-oxoethyl) (4Z)-4-(thiophen-2-ylmethylidene)-2,3-dihydro-1H-acridine-9-carboxylate
(2R,3S)-cis-epsilon-viniferin
A stilbenoid that is the (2R,3S)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.
(2S,3R)-cis-epsilon-viniferin
A stilbenoid that is the (2S,3R)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.
(2S,3R)-trans-epsilon-viniferin
A stilbenoid that is the (2S,3R)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.
7-[(3-Bromophenyl)methyl]-1,3-dimethyl-8-(3-pyridinylmethylamino)purine-2,6-dione
4-fluoro-N-[2-[(2R,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
[(3aS,4S,9bS)-8-(3-methoxyphenyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C23H26N4O4S (454.16746760000007)
[(2S,3R)-3-phenyl-1-(phenylmethyl)sulfonyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
4-fluoro-N-[2-[(2R,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
4-fluoro-N-[2-[(2S,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
4-fluoro-N-[2-[(2S,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
[(3aR,4R,9bR)-8-(3-methoxyphenyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C23H26N4O4S (454.16746760000007)
(6S,7R,8S)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
4-fluoro-N-[2-[(2S,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
4-fluoro-N-[2-[(2R,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
4-fluoro-N-[2-[(2R,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
4-fluoro-N-[2-[(2S,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]benzamide
C21H24F2N2O5S (454.13739180000005)
[(3aR,4S,9bR)-8-(3-methoxyphenyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
C23H26N4O4S (454.16746760000007)
(6S,7S,8R)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-4-[(2-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
[(E)-4-[3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl]-2-methylbut-2-enyl] hydrogen sulate
3,4,5-Trihydroxy-6-[[3-hydroxy-2-(2-hydroxypropan-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-9-yl]oxy]oxane-2-carboxylic acid
8,16-Dihydroxy-6-(6-hydroxy-1-benzouran-2-yl)-12-methyl-3,13-dioxapentacyclo[10.7.1.02,10.04,9.014,19]icosa-2(10),4,6,8,14(19),15,17-heptaen-11-one
(2R,5S)-1,4-Dimethyl-2-hydroxy-2-(3,4-dihydroxybenzyl)-5-[(4-nitro-1H-indol-3-yl)methyl]piperazine-3,6-dione
sodium;(2R,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
C21H23N2NaO6S (454.11744580000004)
4,7-DI(Para-ethoxyphenyl)-6-(pyridin-4-YL)-1,2,5-thiadiazolo(3,4-C)pyridine
(2S,3S)-trans-delta-viniferin
A stilbenoid that is the (2S,3S)-trans-stereoisomer of delta-viniferin, obtained by cyclodimerisation of trans-resveratrol.
(+)-trans-epsilon-viniferin
A stilbenoid that is the (+)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.
hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester
C20H23O10P (454.10287880000004)
An organic phosphonate that is the trisacetoxymethylester derivative of naphthalene substituted hydroxymethylphosphonic acid. It has been found to inhibit insulin receptor tyrosine kinase activity and insulin stimulated glucose oxidation.
(2R,3S)-trans-epsilon-viniferin
A stilbenoid that is the (2R,3S)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.
(-)-cis-epsilon-viniferin
A stilbenoid that is the (-)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.
S-hexanoyl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-hexanoyl-4-phosphopantetheine; major species at pH 7.3.
(2R,3R)-trans-delta-viniferin
A stilbenoid that is the (2R,3R)-trans-stereoisomer of delta-viniferin, obtained by cyclodimerisation of trans-resveratrol.
MK-3903
MK-3903 is a potent and selective AMP-activated protein kinase (AMPK) activator with an EC50 of 8 nM.
ML349
ML349 is a potent and specific acyl protein thioesterase 2(APT2)/lysophospholipase 2 (LYPLA2) inhibitor with a Ki of 120 nM. ML349 is also an inhibitor of LYPLA2 with an IC50 of 144 nM[1][2].
SIRT6 activator 12q
SIRT6 activator 12q is potent, selective and orally active SIRT6 activator with IC50 values of 171.20, >200, >200, >200, 0.58 μM for SIRT1, SIRT2, SIRT3, SIRT5, SIRT6, respectively. SIRT6 activator 12q inhibits cell growth and migration. SIRT6 activator 12q induces Apoptosis and cell cycle arrest at G2 phase. SIRT6 activator 12q shows anticancer activity[1].
5-acetyl-3,10,10,14,18-pentamethyl-20-methylidene-9,17,19-trioxahexacyclo[9.7.1.1³,¹⁵.0¹,¹⁵.0⁵,¹⁴.0⁶,¹¹]icos-6-ene-2,8,12,16-tetrone
4-(acetyloxy)-5-cyano-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-2-yl acetate
C22H18N2O9 (454.10122579999995)
8,16-bis(4-hydroxyphenyl)tetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,10,12,14-hexaene-3,5,12,14-tetrol
ethyl (2r)-4-hydroxy-2-[(3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methyl]-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
5,7-dihydroxy-2-(hydroxymethyl)-8-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl)chromen-4-one
C21H26O11 (454.14750460000005)
(4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-yl)methyl 4-hydroxy-3-methoxybenzoate
4-hydroxy-2-(2-hydroxypropan-2-yl)-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h,3h-furo[3,2-g]chromen-5-one
C21H26O11 (454.14750460000005)
4-[6-hydroxy-2-(4-hydroxyphenyl)-4-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-3-yl]benzene-1,2-diol
4-hydroxy-6-[4-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-2-(2-hydroxypropan-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
3'-hydroxy-10'-(hydroxymethyl)-4,4,5,11'-tetramethyl-3,9',12'-trioxo-13'-thia-8',11'-diazaspiro[oxolane-2,5'-tetracyclo[8.2.1.0¹,⁸.0³,⁷]tridecan]-4'-yl acetate
C20H26N2O8S (454.14097960000004)